Profile image
Story Views

Last Hour:
Last 24 Hours:

World Regenerative Medicine Market is Expected to Reach $30,237 Million by 2022 at a CAGR of 33.1% During 2016-2022

Monday, October 24, 2016 4:20
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Research Beam added a report on “Regenerative Medicine Market by technology (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecules & Biologics), Material (Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Material, Collagen, Xenogeneic Material, Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells Three-Dimensional Polymer Technology, Transgenic, Fibroblasts, Neural Stem Cells Gene-Activated Matrices, Small Molecules, and Biologics) and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology and Others) – Global Opportunity Analysis and Industry Forecasts, 2014 – 2022

Regenerative medicines hold the ability to replace, repair, and regenerate tissues and organs that are affected due to some disease, injury, or natural ageing process. These medicines are capable of restoring the functionality of tissues & cells applicable in a wide range of degenerative disorders such as neurodegenerative diseases, dermatology, cardiovascular and orthopedic applications. Researchers have been focusing on the development of advanced technologies based on genes, biologics, somatic cells and stem cells. Stem cells have the capability to proliferate and differentiate owing to which they are of importance in this field. Currently, predominant treatments available for degenerative or life-threatening diseases do not provide a treatment or are palliative; however, regenerative medicines have the ability to replace or regenerate the tissues and organs suffering from injury or disease. Moreover, the exploitation of nano-materials in drug delivery, wound care and immunomodulation are opportunistic for the regenerative medicine market.

The growth of this market is attributed by the factors such as an emergence of stem cell technology, valuable potential of nanotechnology, rising prevalence of chronic diseases & trauma emergencies, innovation in monitoring devices and surgical technologies. Moreover, rising incidence of degenerative diseases specifically and shortage for organ transplants has boosted the market growth. Furthermore, the increasing focus on stem cells with new source, and getting core competency in the emerging economies are expected to supplement the growth in future. The developing nations are adopting technological advanced treatment modalities at a rapid pace, which is expected to assist in the market expansion worldwide. However, operational inefficiency, stringent regulations, and the high cost of the treatment through regenerative medicine deters the market progression.

The report segments the world regenerative medicine market based on product type, material, application, and geography. Based on product type, it is categorized into cell therapy, gene therapy, tissue engineering, and small molecules & biologics. Cell therapy dominated the market among all other products owing to its efficiency to restore the lost function of any tissue or organ. However, the small molecules & biologics segment is anticipated to grow at a highest CAGR of 34.2% from 2016 to 2022, due to its potential to stimulate dormant or endogenous cells to regain their regenerative properties.

Read More@

Based on material, the market is classified into synthetic materials, biologically derived materials, genetically engineered materials, and pharmaceuticals. The world regenerative medicine market is expected to reach $30,237 million by 2022 at a CAGR of 33.1% during 2016-2022. These materials are further subcategorized into different segments. The biologically derived materials accounted for about 4/7th of total market share in 2015, and is estimated to retain its position during the analysis period. The increasing demand for genetically engineered materials specially due to their unique properties such as promotion of increased proliferation, cellular interactions, and differentiation of cells that facilitates self-assembly into organized structures, and controlling the manipulation of cellular behavior.

On the basis of application, Regenerative medicine market is segmented as cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. The musculoskeletal application accounted for the largest share in 2015, whereas cardiovascular is expected to be the fastest growing segment at a CAGR of 35.3% during the analysis period.

Key Benefits

  • The report includes an extensive analysis of the factors driving as well as restraining the world regenerative medicine market.
  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 to 2022 that is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product, material, application, and geography helps in understanding the various types of devices used for different chronic abnormalities.
  • Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.

Table of Contents
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodologyCHAPTER 2 EXECUTIVE SUMMARY2.1 CXO perspectiveCHAPTER 3 MARKET OVERVIEW3.1 Market definition and scope
3.2 Key findings3.3 Porters five forces analysis
3.4 Market dynamicsCHAPTER 4 WORLD REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-20224.1 Overview4.2 Cell therapy
4.3 Gene therapy
4.4 Tissue Engineering
4.5 Small molecules and biologicsCHAPTER 5 WORLD REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2015-20225.1 Overview5.2 Synthetic materials
5.3 Biologically derived materialsCHAPTER 6 WORLD REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2015-20226.1 Overview6.2 CardiovascularCHAPTER 7 WORLD REGENERATIVE MEDICINE MARKET, BY GEOGRAPHY, 2015-20227.1 Overview7.2 North AmericaCHAPTER 8 COMPANY PROFILES8.1 Integra Lifesciences Corporation

Download sample@

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.